BioLargo, a cleantech company, has joined the New Jersey PFAS Partnership Innovation Consortium led by NJIT to accelerate PFAS technology development and deployment. Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, was appointed to the consortium's Board of Directors, highlighting the company's role in advancing practical PFAS treatment solutions. BioLargo's patented Aqueous Electrostatic Concentrator (AEC) technology, proven in real-world conditions, will be a key asset in collaborative efforts with universities, regulators, and utilities. This partnership aims to enhance PFAS detection, treatment, and commercialization, supporting cleaner water solutions in New Jersey and beyond.
Frank Patton and Kimberlee Mott, financial advisors with 45 years of combined experience managing about $150 million in assets, have joined Balmville Wealth Group through LPL Financial. They bring a focus on retirement planning and multigenerational ...
Crescent Biopharma announced its second quarter 2026 financial results, highlighting progress in clinical trials for its cancer therapies, including CR-001, a PD-1 x VEGF bispecific antibody, and ADC candidates CR-002 and CR-003. The company is enrol...
Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...
XRP is trading around $1.07 as positive regulatory developments in Hong Kong and the EU support its outlook, including retail trading launch in Hong Kong and EU MiCA authorization. However, ongoing U.S. regulatory uncertainty due to the SEC's appeal ...
The Federal Trade Commission (FTC) is suing healthcare company Hims & Hers for allegedly sharing customers' sensitive medical data with advertisers and tech giants like Meta and Snap without consent. The FTC claims Hims & Hers used pixel trackers to ...
